Originally published by our sister publication Pain Medicine News
By Myles Starr
Data from a survey conducted in August 2023 at three syringe service programs in Massachusetts found that exposure to xylazine through adulterated opioids is associated with wounds distinct from typical injection-related skin and soft tissue infections.
It is important “for providers caring for people exposed to this rapidly changing drug supply to proactively screen patients for xylazine wounds, provide